Longs Drug March Same-Store Sales Rise
Walnut Creek, Calif. Longs Drug Stores Corp. said Thursday its March same-store sales rose 2.8%, crediting the shift of Easter sales into the month.
Front-end same-store sales rose 5.7%, while pharmacy sales edged up 0.1%, Longs said.
Total retail drug store sales for the five-week period ended April 3 rose 4.7% to $474 million, the company said.
Longs said its March sales benefited from the earlier Easter holiday season, but also was hurt by the introduction of several generic drugs that substitute for higher-priced brand name versions.
JCPenney reports weak March sales
PLANO, Texas JCPenney reported that comparable-store sales decreased 12.3% for the five weeks ended April 5, consistent with the company’s most recent guidance. This compares with an 11% increase in last year’s period. Total sales in March decreased 10.3%.
According to the company, sales declines during the month were broad-based across most merchandise categories and areas of the country, including soft sales over the Easter period. Customers are responding positively to new American Living product across all categories in which it is available, and Sephora inside JCPenney continues to experience strong sales results.
Management’s guidance for the four-week period ending May 3, is for a mid- to high-single digit decrease in comparable-store sales, compared to a 3.4% decrease in last year’s April period. This guidance reflects the expectation for a continuation of recent trends and the benefit from an extra day of selling in this year’s April period.
Kohl’s March comps tumble
MENOMONEE FALLS, Wis. Kohl’s reported today that sales for the five-week period ended April 5 decreased 7.9% over the five-week period ended April 7. On a comparable-store basis, sales decreased 15.5%. For the nine weeks ended April 5, total sales decreased 3.2% and comparable-store sales decreased 11.1%.
Larry Montgomery, Kohl’s chairman and ceo, commented, “Sales in weather-sensitive businesses such as shorts, tanks, polos and sandals experienced significant declines on a comparable store basis, contributing to our sales shortfall. We have been conservative in our inventory planning and expense management and will continue to do so until the environment improves.”
The company now expects its first quarter comparable sales to be in the negative high-single digit range and its earnings to be 40 cents to 42 cents per diluted share.